TD Bank reports 5.4% stake in Stoke Therapeutics

The Toronto-Dominion Bank and TD Securities filed an amendment to a Schedule 13G reporting beneficial ownership of 3,175,558 shares of Stoke Therapeutics common stock, equal to 5.4%, with the position stated as of 03/31/2026.

Rhea-AI Filing Summary

The Toronto-Dominion Bank and TD Securities filed an amendment to a Schedule 13G reporting beneficial ownership of 3,175,558 shares of Stoke Therapeutics common stock, equal to 5.4%, with the position stated as of 03/31/2026. The filing is a joint statement: TD Bank reports sole voting and dispositive power over 3,173,258 shares and TD Securities Inc. reports sole voting and dispositive power over 2,300 shares. The filing includes standard disclaimers and a joint filing agreement dated 05/15/2026.

Insights

Securities Compliance Analyst

Joint Schedule 13G amendment reports a passive stake of 5.4% held via banking and broker entities.

The amendment lists a combined beneficial position of 3,175,558 shares as of 03/31/2026, with TD Bank holding sole voting and dispositive power over 3,173,258 shares and TD Securities Inc. holding 2,300 shares. The statement includes the required joint filing agreement executed on 05/15/2026.

Materiality is limited: the position equals 5.4% of the class as reported and is presented under passive reporting conventions; subsequent changes would appear in later amendments or Forms. Cash‑flow treatment and sale intentions are not stated in the excerpt.

Key Figures

Beneficial ownership: 3,175,558 shares Percent of class: 5.4% TD Bank sole voting power: 3,173,258 shares +3 more

6 metrics

Beneficial ownership 3,175,558 shares position reported as of 03/31/2026

Percent of class 5.4% reported percent of outstanding common stock

TD Bank sole voting power 3,173,258 shares sole voting and dispositive power reported

TD Securities sole voting power 2,300 shares sole voting and dispositive power reported

CUSIP 86150R107 Stoke Therapeutics common stock

Joint filing agreement date 05/15/2026 signature date on filing

Key Terms

Schedule 13G/A, beneficial ownership, sole dispositive power

3 terms

Schedule 13G/A regulatory

"filed an amendment to a Schedule 13G reporting beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficial ownership regulatory

"Amount beneficially owned: 3,175,558"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

sole dispositive power regulatory

"sole power to dispose or to direct the disposition of: 3,173,258"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does TD Bank report in Stoke Therapeutics (STOK)?

TD Bank and TD Securities report beneficial ownership of 3,175,558 shares, representing 5.4% of the class as stated. The filing attributes 3,173,258 shares to TD Bank and 2,300 shares to TD Securities Inc.

As of what date is the reported ownership for STOK?

The filing states the position "as of" 03/31/2026. Signatures and the joint filing agreement are dated 05/15/2026, confirming the amendment was executed on that later date.

Who has voting and dispositive power over the reported STOK shares?

The Toronto‑Dominion Bank reports sole voting and sole dispositive power over 3,173,258 shares; TD Securities Inc. reports sole voting and dispositive power over 2,300 shares. The filing notes TD Bank is the parent of TD Securities Inc.

Does the Schedule 13G/A state whether proceeds or sales are planned for STOK shares?

The amendment does not state any planned sales or proceeds. It provides beneficial‑ownership counts, voting/dispositive power breakdowns, and the joint filing agreement; no disposition intentions are disclosed in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 01:46 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Stoke Therapeutics, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

86150R107

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 86150R107

1

Names of Reporting Persons

The Toronto-Dominion Bank

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CANADA (FEDERAL LEVEL)

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,173,258.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,173,258.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,173,258.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

FI

SCHEDULE 13G

CUSIP Number(s): 86150R107

1

Names of Reporting Persons

TD Securities Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ONTARIO, CANADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,300.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,300.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,300.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

FI

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Stoke Therapeutics, Inc.
(b)	Address of issuer's principal executive offices: 45 WIGGINS AVENUE, BEDFORD, MASSACHUSETTS 01730
Item 2.
(a)	Name of person filing: The Toronto-Dominion Bank TD Securities Inc.
(b)	Address or principal business office or, if none, residence: The principal office address of The Toronto-Dominion Bank ("TD Bank"): 66 Wellington Street West 12th Floor TD Tower Toronto, Ontario, Canada M5K 1A2 The principal office address of TD Securities Inc. ("TDSI"): 55 King Street West TD Tower 12th Floor Toronto, Ontario, Canada M5K 1A2
(c)	Citizenship: The Toronto-Dominion Bank - CANADA (FEDERAL LEVEL) TD Securities Inc. - ONTARIO, CANADA
(d)	Title of class of securities: Common Stock, $0.0001 par value per share
(e)	CUSIP No.: 86150R107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
	TD Bank - Bank TDSI - Broker Dealer
Item 4.	Ownership
(a)	Amount beneficially owned: 3,175,558 TD Bank has the sole power to vote or direct the vote and the sole power to dispose or direct the disposition of 3,173,258 of these shares and TDSI has the sole power to vote or direct the vote and the sole power to dispose or direct the disposition of 2,300 of these shares. This schedule is jointly filed by TD Bank and TDSI. TD Bank is the sole owner of TDSI. TD Bank may be deemed to hold an indirect interest in the shares reported herein by TDSI by virtue of its ownership of TDSI. TD Bank disclaims ownership of the shares reported herein by TDSI except to the extent of its pecuniary interest therein. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.
(b)	Percent of class: 5.4 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: The Toronto-Dominion Bank - 3,173,258 TD Securities Inc. - 2,300
	(ii) Shared power to vote or to direct the vote: The Toronto-Dominion Bank - 0 TD Securities Inc. - 0
	(iii) Sole power to dispose or to direct the disposition of: The Toronto-Dominion Bank - 3,173,258 TD Securities Inc. - 2,300
	(iv) Shared power to dispose or to direct the disposition of: The Toronto-Dominion Bank - 0 TD Securities Inc. - 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Toronto-Dominion Bank

Signature:	Christina Petrou
Name/Title:	Christina Petrou / Executive Vice President & Chief Operating Officer
Date:	05/15/2026

TD Securities Inc.

Signature:	Greg Nowakowski
Name/Title:	Greg Nowakowski / Chief Compliance Officer
Date:	05/15/2026

Exhibit Information

Exhibit I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the common stock of Stoke Therapeutics Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Dated: May 15, 2026 THE TORONTO-DOMINION BANK By: /s/ Christina Petrou Title: Executive Vice President & Chief Operating Officer TD SECURITIES INC. By: /s/ Greg Nowakowski Title: Chief Compliance Officer